About This Webinar
Evaluating a drug's potential effects on fertility, reproduction, and development is a critical part of the clinical development and market approval process. The complex physiology in reproduction and development presents unique challenges to the nonclinical research team. In this webinar, Sarah Coe and Johnathan Furr will highlight how to leverage pathology findings to inform developmental and reproductive toxicity (DART) studies and juvenile animal studies (JAS).
Listen to the webinar to learn more regarding:
- Using reproductive pathology endpoints to inform DART study design
- Identifying male reproductive system toxicity using stage-aware evaluation of spermatogenesis
- Reviewing the best histopathology practices for DART and JAS
Complete the form to request this on-demand webinar.
